CIK 1201001
Long positions in SEC Section 13(f) securities (US-listed stocks, ADRs and ETFs), largest first · Δ vs 2025-Q4. A lagged quarterly snapshot (filed ≤45 days after quarter-end); excludes shorts, options, cash, and shares listed only on non-US exchanges — foreign companies held via a US listing or ADR (e.g. Alibaba, TSMC) ARE included.
As filed = each book applied at its quarter-end (what the reported book did) · As copyable = applied at its statutory 45-day filing deadline (what a 13F follower could have earned).
Computing…
Hypothetical modeled performance constructed with hindsight — not actual results, and not indicative of future results. See the Disclaimer.
| Industry group | Weight | Names |
|---|---|---|
| Unclassified | 65.17% | 1 |
| Pharmaceuticals & Biotechnology | 26.96% | 3 |
| Software | 7.88% | 1 |
| # | Ticker | Name | Sector | Weight |
|---|---|---|---|---|
| 1 | KLAR | KLARNA GROUP PLC | Unclassified | 65.17% |
| 2 | GENB | Generate Biomedicines, Inc. | Health Care | 21.33% |
| 3 | YMM | Full Truck Alliance Co. Ltd. | Information Technology | 7.88% |
| 4 | CAMP | Camp4 Therapeutics Corp | Health Care | 5.56% |
| 5 | IPSC | Century Therapeutics, Inc. | Health Care | 0.06% |
4/5 names classified · sector 34.8% of weight · industry 34.8% · mkt cap 27.0%; unclassified names shown, never dropped.
Sector is classified on each name's CURRENT fundamentals, not point-in-time — apparent sector drift can reflect the market re-rating a holding, not a manager trade. 13F is a lagged quarterly snapshot of long positions in US-listed securities only — foreign companies held via a US listing or ADR ARE included, but shares listed only on non-US exchanges (plus shorts, options and cash) are not. Latest quarter: 34.8% of the book is sector-classified (unclassified names shown, never dropped).
Only 0% of book weight classified — the grid is NOT representative of the whole book.
Classified: 0.0% of book weight (0/5 names) · unclassified 100.0%: KLAR, GENB, YMM, CAMP, IPSC. Size: cap 70/20/10 bands; style: value/growth composite on our own metrics — not Morningstar's model.
No contribution data for this period.
| Security | 2024-Q4 | 2025-Q1 | 2025-Q2 | 2025-Q3 | 2025-Q4 | 2026-Q1 | Latest value |
|---|---|---|---|---|---|---|---|
| KLARKLARNA GROUP PLC | — | — | — | 5.0M | 5.0M | 5.0M | $66M |
| GENBGENERATE BIOMEDICINES INC | — | — | — | — | — | 1.7M | $22M |
| YMMFULL TRUCK ALLIANCE CO LTD | 958K | 958K | 958K | 958K | 958K | 958K | $8M |
| CAMPCAMP4 THERAPEUTICS CORP | 1.3M | 1.3M | 1.3M | 1.3M | 1.3M | 1.3M | $6M |
| IPSCCENTURY THERAPEUTICS INC | 29K | 29K | 29K | 29K | 29K | 29K | $65,581 |
Shares reported each quarter by the largest current holdings. Green = added vs the prior filing of that name, red = trimmed, grey = roughly held; a dash is a quarter with no 13F on file (a gap is skipped, not read as an exit). 13F is filed up to 45 days after quarter-end. Up to 40 quarters (10 years) available — use the selector above.
Where this firm's principals came from and which firms its alumni went on to found.
